NO904003L - 1,2,4-benzotriazinoksider som radiosensibiliseringsmidlerog selektive cytotoksiske midler. - Google Patents

1,2,4-benzotriazinoksider som radiosensibiliseringsmidlerog selektive cytotoksiske midler.

Info

Publication number
NO904003L
NO904003L NO90904003A NO904003A NO904003L NO 904003 L NO904003 L NO 904003L NO 90904003 A NO90904003 A NO 90904003A NO 904003 A NO904003 A NO 904003A NO 904003 L NO904003 L NO 904003L
Authority
NO
Norway
Prior art keywords
cytotoxic agents
radiosensibilizers
selective cytotoxic
benzotriazine oxides
disclosed
Prior art date
Application number
NO90904003A
Other languages
English (en)
Other versions
NO179005C (no
NO904003D0 (no
NO179005B (no
Inventor
William W Lee
Martin J Brown
Edward W Grange
Abelardo P Martinez
Michael Tracy
Original Assignee
Stanford Res Inst Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int filed Critical Stanford Res Inst Int
Publication of NO904003D0 publication Critical patent/NO904003D0/no
Publication of NO904003L publication Critical patent/NO904003L/no
Publication of NO179005B publication Critical patent/NO179005B/no
Publication of NO179005C publication Critical patent/NO179005C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C07D253/10Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
NO904003A 1988-03-18 1990-09-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,2,4-benzotriazinoksider NO179005C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16987388A 1988-03-18 1988-03-18
PCT/US1989/001037 WO1989008647A1 (en) 1988-03-18 1989-03-15 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents

Publications (4)

Publication Number Publication Date
NO904003D0 NO904003D0 (no) 1990-09-13
NO904003L true NO904003L (no) 1990-09-13
NO179005B NO179005B (no) 1996-04-09
NO179005C NO179005C (no) 1996-07-17

Family

ID=22617563

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904003A NO179005C (no) 1988-03-18 1990-09-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,2,4-benzotriazinoksider

Country Status (14)

Country Link
EP (1) EP0413706B1 (no)
JP (1) JP2793312B2 (no)
KR (1) KR0140894B1 (no)
AT (1) ATE170515T1 (no)
AU (1) AU637572B2 (no)
CA (1) CA1339217C (no)
DE (1) DE68928802T2 (no)
DK (1) DK175885B1 (no)
ES (1) ES2013123A6 (no)
IE (1) IE62911B1 (no)
NO (1) NO179005C (no)
NZ (1) NZ228323A (no)
PT (1) PT90039B (no)
WO (1) WO1989008647A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225965B1 (en) * 1989-09-18 2008-01-28 Stanford Res Inst Int Process for producing medicaments containing 1,2,4-benzotriazine oxides as radiation sensitizers and/or selective cytotoxic agents
US5110347A (en) * 1990-11-26 1992-05-05 E. I Du Pont De Nemours And Company Substituted fused heterocyclic herbicides
EP1723125A4 (en) * 2004-03-01 2009-11-18 Auckland Uniservices Ltd 1,2,4-benzotriazine-1,4-dioxides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2489352A (en) * 1946-04-10 1949-11-29 Merck & Co Inc Halogen compounds of 3 aminobenzotriazine 1, 2, 4 oxide-1
US2489359A (en) * 1947-01-10 1949-11-29 Merck & Co Inc Benzotriazines
CH487171A (de) * 1963-10-22 1970-03-15 Siegfried Ag Verfahren zur Herstellung therapeutisch wirksamer 1,2-Dihydro-1,2,4-benztriazine
DE1809390A1 (de) * 1968-11-16 1970-06-11 Bayer Ag Phosphor-,Phosphon- bzw.Thionophosphor-(-phosphon)-saeureester und Verfahren zu ihrer Herstellung
DE2255825C3 (de) * 1972-11-15 1978-03-30 Bayer Ag, 5090 Leverkusen Mikrobizide Mittel auf der Basis von S-N-Aminobenzo-l^-Triazin-di-N-oxiden (1,4)
IL44058A (en) * 1973-02-02 1978-10-31 Ciba Geigy Ag 3amino-1,2,4-benzotriazine 1,4-di-noxide derivatives, their preparation and compositions for the control of microorganisms containing them
SE7501624L (no) * 1974-03-15 1975-09-16 Ciba Geigy Ag
DE2538179C2 (de) * 1975-08-27 1986-05-28 Bayer Ag, 5090 Leverkusen 3-Alkoxy-benzo-1,2,4-triazine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide
US4091098A (en) * 1977-04-25 1978-05-23 Merck & Co., Inc. 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides
DE2740887A1 (de) * 1977-09-10 1979-03-22 Bayer Ag Mittel zur bekaempfung von pflanzenbakteriosen
GB2203151B (en) * 1986-09-25 1991-05-29 Stanford Res Inst Int 1,2,4-benzotriazine oxides as radiosensitisers and selective cytotoxic agents

Also Published As

Publication number Publication date
NO179005C (no) 1996-07-17
IE890721L (en) 1989-09-18
IE62911B1 (en) 1995-03-08
DK223090A (da) 1990-11-15
WO1989008647A1 (en) 1989-09-21
NO904003D0 (no) 1990-09-13
EP0413706B1 (en) 1998-09-02
EP0413706A1 (en) 1991-02-27
KR0140894B1 (ko) 1998-06-01
PT90039B (pt) 1994-05-31
DE68928802T2 (de) 1999-04-01
AU3433789A (en) 1989-10-05
AU637572B2 (en) 1993-06-03
DE68928802D1 (de) 1998-10-08
ATE170515T1 (de) 1998-09-15
KR900700466A (ko) 1990-08-13
CA1339217C (en) 1997-08-05
NO179005B (no) 1996-04-09
JP2793312B2 (ja) 1998-09-03
PT90039A (pt) 1989-11-10
ES2013123A6 (es) 1990-04-16
DK175885B1 (da) 2005-05-23
NZ228323A (en) 1992-09-25
JPH03505867A (ja) 1991-12-19
DK223090D0 (da) 1990-09-17

Similar Documents

Publication Publication Date Title
MX9200675A (es) Derivados de 2,4-diaminoquinazolinas para mejorar la actividad antitumoral.
NO155622C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido- og isokinolin (1[,2[:1,2) imidazo (5,4-c) rifamycin sv og s derivater.
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
ATE81505T1 (de) Azacycloalkanderivate, absorptionspromotoren, die die derivate als effektiven inhaltsstoff enthalten und aeusserlich anzuwendende praeparate, die absorptionspromotoren enthalten.
SE8504720D0 (sv) New drug preparation
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
NO162965C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydrotieno-(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.
GB8824869D0 (en) Synthetic antibody
ATE34077T1 (de) Hautbehandlungsmittel.
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
SE8700203D0 (sv) Pyroglutamide derivatives
NO163486C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater.
FI902966A0 (fi) Stabil frystorkad polyhematoporfyrineter/esterkomposition.
NO890046L (no) Disubstituerte pyridiner.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
FI892684L (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
NO904003L (no) 1,2,4-benzotriazinoksider som radiosensibiliseringsmidlerog selektive cytotoksiske midler.
HUT42102A (en) Process for preparing peptides with pharmaceutical activity
EP0147707A3 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
GR3004848T3 (no)
NO854277L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 6-fenetylaminoalkyl-7-hydroksy-furo-(3,4-c)-pyridin-derivater.
GB2185254A (en) Benzamide and nicotinamide radiosensitizers
RU97111568A (ru) Способ лечения онкологических больных
TR20690A (tr) Kirisler,raylar veya diger benzer profillerin olusturulmasina mahsus ueniversel bir haddeleme tesisinin bir haddeleme uenitesinin tek bir merdane takimina,bircok degisik haddeleme girintisinin,gecme suretiyle,yerlestirilmesine mahsus usul;merdaneler,haddeleme ueniteleri ve haddeleme tesisleri

Legal Events

Date Code Title Description
MK1K Patent expired